Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Moon

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Current Oncology (Toronto, Ont.)|September 26, 2025
Safety of Combination TARE and SBRT in Hepatocellular Carcinoma: A Review of Literature & Single-Center Case SeriesBahareh Gholami, Ali Afrasiabi, Andrew M Moon, et al.
Digestive Diseases (Basel, Switzerland)|August 25, 2020
Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric DiseaseAndrew M Moon, Stephanie E Watkins, Anna S Lok, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risksSahaj Mujumdar, Sofia Shaikh, Shu-Yen Chan, et al.
Cancers|April 26, 2025
Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular CarcinomasMichael Mohnasky, Sandra Gad, Marco Fanous, et al.
The American Journal of Gastroenterology|April 11, 2025
Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular CarcinomaAndrew M Moon, Gabriel V Lupu, Ellen W Green, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 2, 2024
Evaluating Disparities in COVID-19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe-An International Registry StudyUmar Hayat, Andrew M Moon, Manesh K Gangwani, et al.
AIDS Research and Human Retroviruses|December 17, 2009
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in TanzaniaHumphrey J Shao, John A Crump, Habib O Ramadhani, et al.
Hepatology Communications|October 28, 2021
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 VaccinationAndrew M Moon, Gwilym J Webb, Ignacio García-Juárez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 24, 2023
Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018Christine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
North Carolina Medical Journal|March 11, 2026
Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North CarolinaChristine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Current Oncology (Toronto, Ont.)|September 26, 2025
Safety of Combination TARE and SBRT in Hepatocellular Carcinoma: A Review of Literature & Single-Center Case SeriesBahareh Gholami, Ali Afrasiabi, Andrew M Moon, et al.
Digestive Diseases (Basel, Switzerland)|August 25, 2020
Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric DiseaseAndrew M Moon, Stephanie E Watkins, Anna S Lok, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risksSahaj Mujumdar, Sofia Shaikh, Shu-Yen Chan, et al.
Cancers|April 26, 2025
Initial Experience with Single-Session Resin-Based Transarterial Radioembolization Mapping and Treatment of Small Hepatocellular CarcinomasMichael Mohnasky, Sandra Gad, Marco Fanous, et al.
The American Journal of Gastroenterology|April 11, 2025
Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular CarcinomaAndrew M Moon, Gabriel V Lupu, Ellen W Green, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 2, 2024
Evaluating Disparities in COVID-19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe-An International Registry StudyUmar Hayat, Andrew M Moon, Manesh K Gangwani, et al.
AIDS Research and Human Retroviruses|December 17, 2009
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in TanzaniaHumphrey J Shao, John A Crump, Habib O Ramadhani, et al.
Hepatology Communications|October 28, 2021
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 VaccinationAndrew M Moon, Gwilym J Webb, Ignacio García-Juárez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 24, 2023
Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018Christine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
North Carolina Medical Journal|March 11, 2026
Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North CarolinaChristine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
Pageof 11